Knockouts model the 100 best-selling drugs—will they model the next 100? (original) (raw)

• Drews, J. Biotechnology's metamorphosis into a drug discovery industry. Nature Biotechnol. 16, (Suppl) 22–24 (1998).
  CAS Google Scholar
• Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug Discov. 1, 727–30 (2002). This paper describes the gene families that constitute the druggable genome from the perspective of chemists in the pharmaceutical industry.
  CAS Google Scholar
• PharmaLive.com. The Med Ad News 200- the world's best-selling medicines, May 2002. Engel Publishing Partners, Reprinted with permission from Med Ad News, (May 2002) (PharmaLive.com , West Trenton, NJ, 2002). This is a list of the top 200 selling pharmaceutical drugs of the year 2001.
• FDA. FDA. (Center for Drug Evaluation and Research, Rockville, MD, CDER Report to the Nation, 1997– 2001). The annual CDER Report to the Nation describes the new molecular entities that have been approved by the FDA each year.
• Vinson, M. C., Davis, W. M. & Waters, I. W. (Drug Topics, Montvale, NJ, New Drug Approvals of 1995–1997). Each year, Drug Topics publishes a review of the new drugs approved by the FDA and their mechanism of action.
• Kaitin, K. I. & Manocchia, M. The new drug approvals of 1993, 1994, and 1995: trends in drug development. Am. J. Ther. 4, 46–54 (1997).
  CAS PubMed Google Scholar
• Scappini, B. et al. In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells. Cancer 94, 2653–2662 (2002).
  CAS PubMed Google Scholar
• Walke, D. W. et al. In vivo drug target discovery: identifying the best targets from the genome. Curr. Opin. Biotechnol. 12, 626–631 (2001).
  CAS PubMed Google Scholar
• Abuin, A., Holt, K. H., Platt, K. A., Sands, A. T. & Zambrowicz, B. P. Full-speed mammalian genetics: in vivo target validation in the drug discovery process. Trends Biotechnol. 20, 36–42 (2002).
  CAS PubMed Google Scholar
• BusinessCommunicationsCompany. (Business Communications Company, Inc., Norwalk, CT, 2002).
• Spicer, Z. et al. Stomachs of mice lacking the gastric H,K-ATPase α-subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. J. Biol. Chem. 275, 21555–21565 (2000). This is an example of a target knockout modelling a small-molecule antagonist of the same target.
  CAS PubMed Google Scholar
• Scarff, K. L., Judd, L. M., Toh, B. H., Gleeson, P. A. & Van Driel, I. R. Gastric H(+),K(+)-adenosine triphosphatase β subunit is required for normal function, development, and membrane structure of mouse parietal cells. Gastroenterology 117, 605–668 (1999).
  CAS PubMed Google Scholar
• Kobayashi, T. et al. Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. J. Clin. Invest. 105, 1741–1749 (2000).
  CAS PubMed PubMed Central Google Scholar
• Wu, C. S., Lim, S. K., D'Agati, V. & Costantini, F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59–67 (1996).
  Google Scholar
• Lieschke, G. J. et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737–1746 (1994). This is an example of a knockout of a therapeutic protein showing the opposite phenotype to the effect produced by treatment with the same therapeutic protein.
  CAS PubMed Google Scholar
• Banu, Y. & Watanabe, T. Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling. J. Exp. Med. 189, 673–682 (1999).
  CAS PubMed PubMed Central Google Scholar
• Jutel, M. et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420–425 (2001).
  CAS PubMed Google Scholar
• Yanai, K. et al. Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience 87, 479–487 (1998).
  CAS PubMed Google Scholar
• Inoue, I. et al. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc. Natl Acad. Sci. USA 93, 13316–13320 (1996).
  CAS PubMed PubMed Central Google Scholar
• Yanai, K., Son, L. Z., Endou, M., Sakurai, E. & Watanabe, T. Targeting disruption of histamine H1 receptors in mice: behavioral and neurochemical characterization. Life Sci. 62, 1607–1610 (1998).
  CAS PubMed Google Scholar
• Tilley, S. L., Coffman, T. M. & Koller, B. H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108, 15–23 (2001).
  CAS PubMed PubMed Central Google Scholar
• Morteau, O. Prostaglandins and inflammation: the cyclooxygenase controversy. Arch. Immunol. Ther. Exp. 48, 473–480 (2000).
  CAS Google Scholar
• Austin, S. C. & Funk, C. D. Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions. Prostaglandins Other Lipid Mediat. 58, 231–252 (1999).
  CAS PubMed Google Scholar
• Langenbach, R., Loftin, C., Lee, C. & Tiano, H. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. Biochem. Pharmacol. 58, 1237–1246 (1999).
  CAS PubMed Google Scholar
• Williams, C. S., Mann, M. & DuBois, R. N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18, 7908–7916 (1999).
  CAS PubMed Google Scholar
• Langenbach, R. et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83, 483–492 (1995).
  CAS PubMed Google Scholar
• Langenbach, R., Loftin, C. D., Lee, C. & Tiano, H. Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann. NY Acad. Sci. 889, 52–61 (1999).
  CAS PubMed Google Scholar
• Reddy, S. T., Tiano, H. F., Langenbach, R., Morham, S. G. & Herschman, H. R. Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells. Biochem. Biophys. Res. Commun. 265, 205–210 (1999).
  CAS PubMed Google Scholar
• Morteau, O. et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest. 105, 469–478 (2000).
  CAS PubMed PubMed Central Google Scholar
• Ballou, L. R., Botting, R. M., Goorha, S., Zhang, J. & Vane, J. R. Nociception in cyclooxygenase isozyme-deficient mice. Proc. Natl Acad. Sci. USA 97, 10272–10276 (2000).
  CAS PubMed PubMed Central Google Scholar
• Chulada, P. C. et al. Cycloxygenase-1 and-2 deficiency decrease spontaneous intestinal adenomas in the Min mouse. Proc. Am. Assoc. Cancer Res. 39, 195 (1998).
  Google Scholar
• Tiano, H. F. et al. Effects of cyclooxygenase deficiency on inflammation and papilloma formation in mouse skin. Proc. Am. Assoc. Cancer Res. 38, 257 (1998).
  Google Scholar
• Morham, S. G. et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473–482 (1995).
  CAS PubMed Google Scholar
• Li, S. et al. The febrile response to lipopolysaccharide is blocked in cyclooxygenase- 2(−/−), but not in cyclooxygenase-1(−/−) mice. Brain Res. 825, 86–94 (1999).
  CAS PubMed Google Scholar
• Myers, L. K. et al. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 43, 2687–2693 (2000).
  CAS PubMed Google Scholar
• Oshima, M. et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803–809 (1996).
  CAS PubMed Google Scholar
• Irvin, C. G., Tu, Y. P., Sheller, J. R. & Funk, C. D. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am. J. Physiol. 272, L1053–1058 (1997).
  CAS PubMed Google Scholar
• Peters-Golden, M. et al. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am. J. Respir. Crit. Care Med. 165, 229–235 (2002).
  PubMed Google Scholar
• Chen, X. S., Sheller, J. R., Johnson, E. N. & Funk, C. D. Role of leukotrienes revealed by targeted disruption of the 5- lipoxygenase gene. Nature 372, 179–182 (1994).
  CAS PubMed Google Scholar
• Maekawa, A., Austen, K. F. & Kanaoka, Y. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J. Biol. Chem. 277, 20820–20824 (2002).
  CAS PubMed Google Scholar
• Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNF α-deficient mice: a critical requirement for TNF α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397–1411 (1996). This is an example of a knockout of a therapeutic antibody product showing aspects of the phenotype produced by treatment with the therapeutic antibody that neutralizes the target.
  CAS PubMed Google Scholar
• Marino, M. W. et al. Characterization of tumor necrosis factor-deficient mice. Proc. Natl Acad. Sci. USA 94, 8093–8098 (1997).
  CAS PubMed PubMed Central Google Scholar
• Gu, J. J. et al. Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene. J. Clin. Invest. 106, 599–606 (2000).
  CAS PubMed PubMed Central Google Scholar
• Schmid, W., Cole, T. J., Blendy, J. A. & Schutz, G. Molecular genetic analysis of glucocorticoid signalling in development. J. Steroid Biochem. Mol. Biol. 53, 33–35 (1995).
  CAS PubMed Google Scholar
• Reichardt, H. M., Tronche, F., Bauer, A. & Schutz, G. Molecular genetic analysis of glucocorticoid signaling using the Cre/loxP system. Biol. Chem. 381, 961–964 (2000).
  CAS PubMed Google Scholar
• Bueno, O. F., Brandt, E. B., Rothenberg, M. E. & Molkentin, J. D. Defective T cell development and function in calcineurin A β- deficient mice. Proc. Natl Acad. Sci. USA 99, 9398–9403 (2002).
  CAS PubMed PubMed Central Google Scholar
• Malleret, G., Hen, R., Guillou, J. L., Segu, L. & Buhot, M. C. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J. Neurosci. 19, 6157–6168 (1999).
  CAS PubMed PubMed Central Google Scholar
• Grailhe, R. et al. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron 22, 581–591 (1999).
  CAS PubMed Google Scholar
• Tecott, L. H., Logue, S. F., Wehner, J. M. & Kauer, J. A. Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice. Proc. Natl Acad. Sci. USA 95, 15026–15031 (1998).
  CAS PubMed PubMed Central Google Scholar
• Ramboz, S. et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc. Natl Acad. Sci. USA 95, 14476–14481 (1998).
  CAS PubMed PubMed Central Google Scholar
• Parks, C. L., Robinson, P. S., Sibille, E., Shenk, T. & Toth, M. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl Acad. Sci. USA 95, 10734–10739 (1998).
  CAS PubMed PubMed Central Google Scholar
• Heisler, L. K. et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl Acad. Sci. USA 95, 15049–15054 (1998).
  CAS PubMed PubMed Central Google Scholar
• Ramboz, S. et al. 5-HT1B receptor knock out—behavioral consequences. Behav. Brain Res. 73, 305–312 (1996).
  CAS PubMed Google Scholar
• Mayorga, A. J. et al. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5- hydroxytryptamine(1B) receptor mutant mice. J. Pharmacol. Exp. Ther. 298, 1101–1107 (2001).
  CAS PubMed Google Scholar
• Dulawa, S. C., Grandy, D. K., Low, M. J., Paulus, M. P. & Geyer, M. A. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci. 19, 9550–9556 (1999).
  CAS PubMed PubMed Central Google Scholar
• Kelly, M. A. et al. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J. Neurosc.i 18, 3470–3479 (1998).
  CAS Google Scholar
• Xu, M. et al. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19, 837–848 (1997).
  CAS PubMed Google Scholar
• Smith, D. R. et al. Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience 86, 135–146 (1998).
  CAS PubMed Google Scholar
• Xu, M. et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79, 729–742 (1994).
  CAS PubMed Google Scholar
• Rubinstein, M. et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90, 991–1001 (1997).
  CAS PubMed Google Scholar
• Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606–612 (1996).
  CAS PubMed Google Scholar
• Xu, F. et al. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nature Neurosci. 3, 465–471 (2000).
  CAS PubMed Google Scholar
• Homanics, G. E. et al. Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. Natl Acad. Sci. USA 94, 4143–4148 (1997).
  CAS PubMed PubMed Central Google Scholar
• Sora, I. et al. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl Acad. Sci. USA 94, 1544–1549 (1997). This is an example of a target knockout producing the opposite phenotype compared to a small molecule agonist of the same target.
  CAS PubMed PubMed Central Google Scholar
• Schomberg, D. W. et al. Targeted disruption of the estrogen receptor-α gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology 140, 2733–2744 (1999).
  CAS PubMed Google Scholar
• Dupont, S. et al. Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development 127, 4277–4291 (2000).
  CAS PubMed Google Scholar
• Vidal, O. et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc. Natl Acad. Sci. USA 97, 5474–5479. (2000).
  CAS PubMed PubMed Central Google Scholar
• Krege, J. H. et al. Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc. Natl Acad. Sci. USA 95, 15677–15682 (1998).
  CAS PubMed PubMed Central Google Scholar
• Dunford, J. E. et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J. Pharmacol. Exp. Ther. 296, 235–242 (2001).
  CAS PubMed Google Scholar
• Thompson, K., Dunford, J. E., Ebetino, F. H. & Rogers, M. J. Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase. Biochem. Biophys. Res. Commun. 290, 869–873 (2002).
  CAS PubMed Google Scholar
• Grove, J. E., Brown, R. J. & Watts, D. J. The intracellular target for the antiresorptive aminobisphosphonate drugs in Dictyostelium discoideum is the enzyme farnesyl diphosphate synthase. J. Bone. Miner. Res. 15, 971–981 (2000).
  CAS PubMed Google Scholar
• Bergstrom, J. D., Bostedor, R. G., Masarachia, P. J., Reszka, A. A. & Rodan, G. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch. Biochem. Biophys. 373, 231–241 (2000).
  CAS PubMed Google Scholar
• Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167–1174 (2001).
  CAS PubMed PubMed Central Google Scholar
• Abu-Elheiga, L., Matzuk, M. M., Abo-Hasema, K. A. H. & Wakil, S. J. Continuous fatty acid oxidation and reduced fat storage in mice lacking Acetyl-CoA carboxylase 2. Science 291, 2613–2616 (2001).
  CAS PubMed Google Scholar
• Leroux, L. et al. Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. Diabetes 50, (Suppl 1) S150–153 (2001).
  CAS PubMed Google Scholar
• Joshi, R. L. et al. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 15, 1542–1547 (1996).
  CAS PubMed PubMed Central Google Scholar
• Accili, D. et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nature Genet 12, 106–109 (1996).
  CAS PubMed Google Scholar
• Wang, J. et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the Mody mouse. J. Clin. Invest. 103, 27–37 (1999).
  CAS PubMed PubMed Central Google Scholar
• Oyadomari, S. et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Invest. 109, 525–532 (2002).
  CAS PubMed PubMed Central Google Scholar
• Miles, P. D., Barak, Y., He, W., Evans, R. M. & Olefsky, J. M. Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency. J. Clin. Invest. 105, 287–292 (2000).
  CAS PubMed PubMed Central Google Scholar
• Lowe, M. E., Kaplan, M. H., Jackson-Grusby, L., D'Agostino, D. & Grusby, M. J. Decreased neonatal dietary fat absorption and T cell cytotoxicity in pancreatic lipase-related protein 2-deficient mice. J. Biol. Chem. 273, 31215–31221 (1998).
  CAS PubMed Google Scholar
• Weng, W. et al. Intestinal absorption of dietary cholesteryl ester is decreased but retinyl ester absorption is normal in carboxyl ester lipase knockout mice. Biochemistry 38, 4143–4149 (1999).
  CAS PubMed Google Scholar
• Ito, M. et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl Acad. Sci. USA 92, 3521–3525 (1995).
  CAS PubMed PubMed Central Google Scholar
• Sugaya, T. et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J. Biol. Chem. 270, 18719–18722 (1995).
  CAS PubMed Google Scholar
• Esther, C. R., Jr. et al. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab. Invest. 74, 953–65 (1996).
  CAS PubMed Google Scholar
• Krege, J. H. et al. Male-female differences in fertility and blood pressure in ACE- deficient mice. Nature 375, 146–148 (1995).
  CAS PubMed Google Scholar
• Foster, C. J. et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J. Clin. Invest. 107, 1591–1598 (2001).
  CAS PubMed PubMed Central Google Scholar
• Dewerchin, M. et al. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb. Haemost. 83, 185–190 (2000).
  CAS PubMed Google Scholar
• Chruscinski, A. et al. Differential distribution of β-adrenergic receptor subtypes in blood vessels of knockout mice lacking β1- or β2-adrenergic receptors. Mol. Pharmacol. 60, 955–962 (2001).
  CAS PubMed Google Scholar
• Naga Prasad, S. V., Nienaber, J. & Rockman, H. A. β-adrenergic axis and heart disease. Trends Genet. 17, S44–49 (2001).
  CAS PubMed Google Scholar
• Eckhart, A. D. & Koch, W. J. Transgenic studies of cardiac adrenergic receptor regulation. J. Pharmacol. Exp. Ther. 299, 1–5 (2001).
  CAS PubMed Google Scholar
• Kaumann, A. J., Engelhardt, S., Hein, L., Molenaar, P. & Lohse, M. Abolition of (-)-CGP 12177-evoked cardiostimulation in double β1/β2-adrenoceptor knockout mice. Obligatory role of β1-adrenoceptors for putative β4-adrenoceptor pharmacology. Naunyn. Schmiedebergs Arch. Pharmacol. 363, 87–93 (2001).
  CAS PubMed Google Scholar
• Rohrer, D. K., Chruscinski, A., Schauble, E. H., Bernstein, D. & Kobilka, B. K. Cardiovascular and metabolic alterations in mice lacking both β1- and β2-adrenergic receptors. J. Biol. Chem. 274, 16701–8. (1999).
  CAS PubMed Google Scholar
• Chruscinski, A. J. et al. Targeted disruption of the β2 adrenergic receptor gene. J. Biol. Chem. 274, 16694–700 (1999).
  CAS PubMed Google Scholar
• Rohrer, D. K. Physiological consequences of β-adrenergic receptor disruption. J. Mol. Med. 76, 764–772 (1998).
  CAS PubMed Google Scholar
• Lowell, B. B. Using gene knockout and transgenic techniques to study the physiology and pharmacology of β3-adrenergic receptors. Endocr. J. 45 (Suppl) S9–13 (1998).
  CAS PubMed Google Scholar
• Preitner, F. et al. Metabolic response to various β-adrenoceptor agonists in β3-adrenoceptor knockout mice: evidence for a new β-adrenergic receptor in brown adipose tissue. Br. J. Pharmacol. 124, 1684–1688 (1998).
  CAS PubMed PubMed Central Google Scholar
• Rohrer, D. K., Schauble, E. H., Desai, K. H., Kobilka, B. K. & Bernstein, D. Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse. Am. J. Physiol. 274, H1184–1193 (1998).
  CAS PubMed Google Scholar
• Kaumann, A. J. et al. (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative β4-adrenoceptors in both wild-type and β3-adrenoceptor knockout mice. Mol. Pharmacol. 53, 670–675 (1998).
  CAS PubMed Google Scholar
• Rohrer, D. K. et al. The developmental and physiological consequences of disrupting genes encoding β1 and β2 adrenoceptors. Adv. Pharmacol. 42, 499–501 (1998).
  CAS PubMed Google Scholar
• Rohrer, D. K. et al. Targeted disruption of the mouse β1-adrenergic receptor gene: developmental and cardiovascular effects. Proc. Natl Acad. Sci. USA 93, 7375–7380 (1996).
  CAS PubMed PubMed Central Google Scholar
• Matsui, M. et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc. Natl Acad. Sci. USA 97, 9579–9584 (2000).
  CAS PubMed PubMed Central Google Scholar
• Li, E., Sucov, H. M., Lee, K. F., Evans, R. M. & Jaenisch, R. Normal development and growth of mice carrying a targeted disruption of the α 1 retinoic acid receptor gene. Proc. Natl Acad. Sci. USA 90, 1590–1594 (1993).
  CAS PubMed PubMed Central Google Scholar
• Luo, J., Pasceri, P., Conlon, R. A., Rossant, J. & Giguere, V. Mice lacking all isoforms of retinoic acid receptor β develop normally and are susceptible to the teratogenic effects of retinoic acid. Mech. Dev. 53, 61–71 (1995).
  CAS PubMed Google Scholar
• Lohnes, D. et al. Function of retinoic acid receptor γ in the mouse. Cell 73, 643–658 (1993).
  CAS PubMed Google Scholar
• Kwan, K. Y. & Wang, J. C. Mice lacking DNA topoisomerase IIIβ develop to maturity but show a reduced mean lifespan. Proc. Natl Acad. Sci. USA 98, 5717–5721 (2001).
  CAS PubMed PubMed Central Google Scholar
• Rao, C. V. & Lei, Z. M. Consequences of targeted inactivation of LH receptors. Mol. Cell. Endocrinol. 187, 57–67 (2002).
  CAS PubMed Google Scholar
• O'Keefe, T. L., Williams, G. T., Davies, S. L. & Neuberger, M. S. Mice carrying a CD20 gene disruption. Immunogenetics 48, 125–132 (1998).
  CAS PubMed Google Scholar
• Mural, R. J. et al. A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science 296, 1661–1671 (2002).
  CAS PubMed Google Scholar
• Saftig, P. et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl Acad. Sci. USA 95, 13453–13458 (1998).
  CAS PubMed PubMed Central Google Scholar
• Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131–141 (1997).
  CAS PubMed Google Scholar
• Chen, A. S. et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nature Genet. 26, 97–102 (2000).
  CAS PubMed Google Scholar
• Chen, Y. et al. Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 143, 2469–2477 (2002).
  CAS PubMed Google Scholar
• Marsh, D. J. et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc. Natl Acad. Sci. USA 99, 3240–3245 (2002).
  CAS PubMed PubMed Central Google Scholar
• Ntambi, J. M. et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl Acad. Sci. USA 99, 11482–11486 (2002).
  CAS PubMed PubMed Central Google Scholar